PepJunkie Home of the Peptonauts
More

Peptide Atlas · Vitamin

Biotin

In a randomized, double-blind trial in 154 people with progressive multiple sclerosis, high-dose biotin (MD1003, 100 mg three times daily) reversed disability in 12.6% against none on placebo.

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 1 citation resolves to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Biotin. Tier reflects study design, not enthusiasm.
ClaimTierSource
High-dose biotin reversed disability in a subset with progressive MS (RCT, n=154)emergingpmid 27589059

Unanswered questions

  • High biotin intake is reported to interfere with laboratory immunoassays; which tests are affected, and at what doses? open

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.